PSP Research LLC
CIK 2106939 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $187.9M
- Posisi
- 75
- Per tanggal
- 30 Juni 2026
#6.648 dari 9.443 berdasarkan nilai 13F · top 70.4%
Nilai portofolio QoQ: +32.9% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 88,03%
- Bobot 25 kepemilikan teratas
- 92,09%
- Posisi di atas 1%
- 2
- Jumlah posisi efektif
- 2,7
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 10,05% Perkiraan pembelian $47.886.212 · penjualan $16.542.557
- Posisi baru
- 11
- Meningkat
- 1
- Menurun
- 30
- Tertutup
- 15
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 99,7% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
14,0%
Lainnya/Tidak terpetakan
86,0%
Portofolio lengkap 75 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| XBI XBI | $90.202.500 | 48,01% | 570.000 | $53.812.223 | Naik ×1 | ||
| SGOV iShares 0-3 Month Treasury Bond ETF | $70.469.000 | 37,51% | 700.000 | $7.000 | |||
| RPRX Royalty Pharma plc - Class A Ordinary Shares | $616.770 | 0,33% | 11.000 | $89.100 | |||
| NRIX Nurix Therapeutics, Inc. - Common stock | $606.500 | 0,32% | 25.000 | $161.650 | Turun ×2 | ||
| INCY Incyte Corporation - Common Stock | $600.808 | 0,32% | 5.300 | $101.972 | |||
| ARGX argenx SE - American Depositary Shares | $594.701 | 0,32% | 641 | $126.611 | |||
| IRON Disc Medicine, Inc. - Common Stock | $585.120 | 0,31% | 8.000 | $73.600 | |||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $583.380 | 0,31% | 14.000 | $145.320 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $567.630 | 0,30% | 17.000 | $104.635 | Turun ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $559.500 | 0,30% | 30.000 | $201.600 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $556.600 | 0,30% | 23.000 | $96.000 | Turun ×1 | ||
| TGTX TG Therapeutics, Inc. - Common Stock | $549.400 | 0,29% | 10.000 | $117.540 | Turun ×2 | ||
| HALO Halozyme Therapeutics, Inc. - Common Stock | $547.890 | 0,29% | 7.000 | $29.170 | Turun ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $539.172 | 0,29% | 6.800 | $28.560 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $518.700 | 0,28% | 15.000 | $-46.300 | Turun ×2 | ||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $516.534 | 0,27% | 19.700 | $52.402 | |||
| AUPH Aurinia Pharmaceuticals Inc - Common Shares | $509.100 | 0,27% | 30.000 | $64.500 | |||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $505.605 | 0,27% | 3.000 | $-1.331 | Turun ×1 | ||
| IMVT Immunovant, Inc. - Common Stock | $500.890 | 0,27% | 13.000 | $23.962 | Turun ×2 | ||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $500.080 | 0,27% | 19.766 | $60.089 | |||
| PTCT PTC Therapeutics, Inc. - Common Stock | $489.420 | 0,26% | 6.000 | $80.640 | |||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $483.730 | 0,26% | 13.000 | $71.370 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $480.727 | 0,26% | 15.141 | $24.226 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $470.400 | 0,25% | 10.000 | $-187.320 | Turun ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $464.400 | 0,25% | 12.000 | $2.520 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $458.680 | 0,24% | 4.000 | $-66.047 | Turun ×2 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $444.200 | 0,24% | 20.000 | $81.600 | |||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $441.009 | 0,23% | 1.465 | $-43.716 | |||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $440.580 | 0,23% | 7.000 | $-50.470 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $437.200 | 0,23% | 20.000 | $-30.000 | |||
| EXEL Exelixis, Inc. - Common Stock | $435.280 | 0,23% | 8.000 | $-77.170 | Turun ×1 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $411.620 | 0,22% | 11.000 | $12.100 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $406.680 | 0,22% | 12.000 | $-73.470 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $400.080 | 0,21% | 1.500 | Naik ×1 | |||
| LQDA Liquidia Corporation - Common Stock | $398.650 | 0,21% | 5.000 | ||||
| STOK Stoke Therapeutics, Inc. - Common Stock | $392.640 | 0,21% | 12.000 | $1.920 | |||
| VKTX Viking Therapeutics, Inc. - Common Stock | $390.100 | 0,21% | 10.000 | $-98.000 | Turun ×1 | ||
| IMNM Immunome, Inc. - Common Stock | $381.420 | 0,20% | 18.000 | $-55.980 | Turun ×2 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $367.740 | 0,20% | 3.000 | $51.540 | |||
| HRMY Harmony Biosciences Holdings, Inc. - Common Stock | $364.100 | 0,19% | 10.000 | $-35.967 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $355.250 | 0,19% | 7.000 | $80.850 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $355.120 | 0,19% | 4.000 | $94.900 | Turun ×2 | ||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $338.400 | 0,18% | 20.000 | $-6.458 | Turun ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $322.170 | 0,17% | 600 | $8.088 | |||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $319.750 | 0,17% | 5.000 | $-113.600 | Turun ×2 | ||
| ALKS Alkermes plc - Ordinary Shares | $314.370 | 0,17% | 6.000 | $102.210 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $312.600 | 0,17% | 10.000 | $11.352 | Turun ×1 | ||
| ARDX Ardelyx, Inc. - Common Stock | $306.000 | 0,16% | 60.000 | $-173.200 | Turun ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $300.370 | 0,16% | 7.000 | $-101.930 | Turun ×1 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $292.675 | 0,16% | 2.500 | $-169.225 | Turun ×2 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $285.510 | 0,15% | 3.000 | $41.830 | Turun ×1 | ||
| SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $279.060 | 0,15% | 6.000 | $-31.080 | |||
| CRSP CRISPR Therapeutics AG - Common Shares | $272.700 | 0,15% | 5.000 | $-179.215 | Turun ×2 | ||
| ZYME Zymeworks Inc. - Common Stock | $261.400 | 0,14% | 10.000 | $11.000 | |||
| KRYS Krystal Biotech, Inc. - Common Stock | $257.196 | 0,14% | 692 | Naik ×1 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $254.700 | 0,14% | 18.000 | $-137.930 | Turun ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $253.512 | 0,13% | 4.200 | $9.282 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $244.770 | 0,13% | 1.000 | $-236.092 | Turun ×1 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $244.604 | 0,13% | 7.041 | Naik ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $243.700 | 0,13% | 2.500 | $-175.900 | Turun ×2 | ||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $233.982 | 0,12% | 971 | ||||
| KOD Kodiak Sciences Inc - Common Stock | $233.760 | 0,12% | 6.000 | $-147.440 | Turun ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $224.736 | 0,12% | 1.200 | ||||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $223.440 | 0,12% | 3.000 | $-222.120 | Turun ×2 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $222.060 | 0,12% | 2.000 | ||||
| DNLI Denali Therapeutics Inc. - Common Stock | $217.668 | 0,12% | 8.463 | ||||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $211.926 | 0,11% | 2.600 | ||||
| SRRK Scholar Rock Holding Corporation - Common Stock | $210.485 | 0,11% | 3.827 | Naik ×1 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $203.150 | 0,11% | 5.000 | $-1.600 | Turun ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $194.650 | 0,10% | 10.838 | $44.002 | |||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $147.750 | 0,08% | 39.400 | Naik ×1 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $147.300 | 0,08% | 15.000 | $20.250 | |||
| EYPT EyePoint, Inc. - Common Stock | $143.000 | 0,08% | 10.000 | $14.100 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $140.790 | 0,07% | 13.000 | $-23.920 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $125.100 | 0,07% | 10.000 | $-24.000 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: K08588103) | $400.080 | 1.500 | 0,21% |
| LQDA | $398.650 | 5.000 | 0,21% |
| KRYS | $257.196 | 692 | 0,14% |
| AVBP | $244.604 | 7.041 | 0,13% |
| JAZZ | $233.982 | 971 | 0,12% |
| RVMD | $224.736 | 1.200 | 0,12% |
| RYTM | $222.060 | 2.000 | 0,12% |
| DNLI | $217.668 | 8.463 | 0,12% |
| ARWR | $211.926 | 2.600 | 0,11% |
| SRRK | $210.485 | 3.827 | 0,11% |
| CTMX | $147.750 | 39.400 | 0,08% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| XBI | Beli lebih banyak | +285K | +$53.8M |
| AXSM | Dipangkas | -2K | -$236K |
| BBIO | Dipangkas | -3K | -$222K |
| TRVI | Hanya pergerakan harga | +0 | +$202K |
| DFTX | Dipangkas | -25K | -$187K |
| CRSP | Dipangkas | -4K | -$179K |
| DNTH | Dipangkas | -2K | -$176K |
| ARDX | Dipangkas | -20K | -$173K |
| MIRM | Dipangkas | -2K | -$169K |
| NRIX | Dipangkas | -4K | +$162K |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| SERA | 30 Juni 2026 | 2.396.685 | $4.865.271 | 12,1% |
| TYRA | 30 Juni 2026 | 16.000 | $612.800 | -16,9% |
| TVTX | 31 Maret 2026 | 15.272 | $583.543 | 118,5% |
| ASND | 30 Juni 2026 | 2.500 | $571.825 | -4,0% |
| JAZZ | 31 Maret 2026 | 3.258 | $553.860 | 34,9% |
| CGON | 31 Maret 2026 | 13.293 | $551.925 | 16,0% |
| BLTE | 31 Maret 2026 | 3.443 | $550.742 | 3,5% |
| APLS | 31 Maret 2026 | 21.866 | $549.274 | Tidak lagi dilacak |
| TERN | 31 Maret 2026 | 13.560 | $547.824 | Tidak lagi dilacak |
| RVMD | 31 Maret 2026 | 6.872 | $547.355 | 124,2% |
| CNTA | 31 Maret 2026 | 21.879 | $547.194 | Tidak lagi dilacak |
| CYTK | 30 Juni 2026 | 8.300 | $547.053 | -10,0% |
| MLYS | 31 Maret 2026 | 14.818 | $537.745 | 0,9% |
| ACLX | 31 Maret 2026 | 8.224 | $536.205 | Tidak lagi dilacak |
| ROIV | 31 Maret 2026 | 24.621 | $534.276 | 33,8% |
| LQDA | 31 Maret 2026 | 15.485 | $534.078 | 95,7% |
| PVLA | 31 Maret 2026 | 5.084 | $532.142 | 20,8% |
| INSM | 31 Maret 2026 | 3.049 | $530.648 | -21,2% |
| NUVL | 31 Maret 2026 | 5.261 | $529.204 | Tidak lagi dilacak |
| VRDN | 31 Maret 2026 | 16.967 | $528.013 | 25,1% |
| WVE | 31 Maret 2026 | 31.040 | $527.680 | -25,1% |
| MAZE | 31 Maret 2026 | 12.672 | $525.001 | -0,3% |
| DNLI | 31 Maret 2026 | 31.762 | $524.391 | 30,5% |
| BMRN | 31 Maret 2026 | 8.772 | $521.320 | 21,2% |
| BEAM | 31 Maret 2026 | 18.334 | $508.218 | 20,2% |
| AGIO | 30 Juni 2026 | 15.000 | $507.450 | -4,5% |
| RYTM | 31 Maret 2026 | 4.738 | $507.156 | 35,1% |
| PRAX | 30 Juni 2026 | 1.500 | $483.285 | 10,3% |
| UPB | 31 Maret 2026 | 17.634 | $478.763 | -21,9% |
| GPCR | 31 Maret 2026 | 6.719 | $467.306 | 11,4% |
| MNMD | 31 Maret 2026 | 34.841 | $466.521 | Tidak lagi dilacak |
| INBX | 30 Juni 2026 | 6.927 | $465.702 | 4,4% |
| ARWR | 31 Maret 2026 | 6.689 | $444.083 | 41,5% |
| ALMS | 31 Maret 2026 | 43.769 | $427.185 | 16,0% |
| ERAS | 30 Juni 2026 | 17.327 | $280.351 | -1,5% |
| CELC | 30 Juni 2026 | 2.000 | $228.280 | -9,3% |
| KALV | 30 Juni 2026 | 10.795 | $217.303 | Tidak lagi dilacak |
| LEGN | 30 Juni 2026 | 12.000 | $217.080 | -21,5% |
| APGE | 30 Juni 2026 | 2.500 | $210.425 | 1,5% |
| UTHR | 30 Juni 2026 | 350 | $207.543 | -1,5% |
| SMMT | 30 Juni 2026 | 10.223 | $193.828 | -11,0% |
| CMPX | 30 Juni 2026 | 30.000 | $158.700 | 13,5% |